Literature DB >> 24268384

Psychiatric disorders in persistent and remitted Sydenham's chorea.

Janaina Moreira1, Arthur Kummer1, Estefânia Harsányi1, Francisco Cardoso2, Antonio L Teixeira3.   

Abstract

BACKGROUND: Sydenham's chorea (SC) has been associated with increased frequency of psychiatric disorders. The objective of the present study was to determine whether there is any difference in the frequency of psychiatric disorders between SC patients in remission and patients with persistent chorea.
METHODS: Fifty consecutive patients with SC (mean age ± SD, years; 21.5 ± 6.7; M/F; 10/40) were subjected to a comprehensive and structured psychiatric evaluation.
RESULTS: The most frequent psychiatric disorders observed in SC patients were: major depression (14%); generalized anxiety disorder (16%), social phobia (24%) and obsessive-compulsive disorder (24%). The frequency of psychiatric disorders did not differ between SC patients in remission in comparison with patients with persistent chorea, except for depressive disorders which were more frequent in the later
CONCLUSIONS: Psychiatric disorders are common among young adults with SC regardless of the status of motor symptoms.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Obsessive-compulsive disorder; Rheumatic fever; Sydenham's chorea

Mesh:

Year:  2013        PMID: 24268384     DOI: 10.1016/j.parkreldis.2013.10.029

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  Chorea: A Journey through History.

Authors:  Thiago Cardoso Vale; Francisco Cardoso
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-05-28

Review 2.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

3.  Comment On: Dance-like Movements in Obsessive Compulsive Disorder.

Authors:  Pooja Yudhishthir Palkar; Anand Ajit Kumthekar
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

Review 4.  Therapeutic aspects of Sydenham's Chorea: an update.

Authors:  Greta Depietri; Niccolo Carli; Attilio Sica; Domenico Oliviero; Giorgio Costagliola; Pasquale Striano; Alice Bonuccelli; Flavia Frisone; Diego Peroni; Rita Consolini; Thomas Foiadelli; Alessandro Orsini
Journal:  Acta Biomed       Date:  2022-03-21

5.  Neurological and Psychiatric Disorders in Patients with Rheumatic Heart Disease: Unveiling what is Beyond Cardiac Manifestations.

Authors:  Luiz Paulo Bastos Vasconcelos; Marcelle Cristina da Silva Bastos Vasconcelos; Francisco Biagio Murta E Di Flora; Flávio Augusto Paes de Oliveira; Pedro Drummond Lima; Lucas Campos Barbosa E Silva; Breno Camargos Mucelli Spolaor; José Luiz Padilha da Silva; William Antônio de Magalhães Esteves; Maria Carmo P Nunes; Antônio Lúcio Teixeira
Journal:  Glob Heart       Date:  2022-08-29

6.  Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham's Chorea: A Multicenter Prospective Study.

Authors:  Alessandro Orsini; Thomas Foiadelli; Attilio Sica; Andrea Santangelo; Niccolò Carli; Alice Bonuccelli; Rita Consolini; Sofia D'Elios; Nicolò Loddo; Alberto Verrotti; Giuseppe Di Cara; Chiara Marra; Maria Califano; Anna Fetta; Marianna Fabi; Stefania Bergamoni; Aglaia Vignoli; Roberta Battini; Marta Mosca; Chiara Baldini; Nadia Assanta; Pietro Marchese; Gabriele Simonini; Edoardo Marrani; Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Salvatore Savasta; Giuseppe Santangelo; Virginia Pedrinelli; Gabriele Massimetti; Liliana Dell'Osso; Diego Peroni; Duccio Maria Cordelli; Martina Corsi; Claudia Carmassi
Journal:  Int J Environ Res Public Health       Date:  2022-08-25       Impact factor: 4.614

7.  Hemiataxia: A Novel Presentation of Anti-NMDA Receptor Antibody Mediated Encephalitis in an Adolescent.

Authors:  Greg D Phillips; Gillian N Jones; Maureen Callaghan; Marc P DiFazio
Journal:  Case Rep Psychiatry       Date:  2017-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.